OnDemand WTP Pricing Research

HHS sued by pharma over rule on prices in ads | POLITICO

HHS SUED OVER DRUG-PRICE RULE — Drugmakers and advertisers on Friday sued the agency over requirements that list prices be included in direct-to-consumer drug ads, saying the rule violated their freedom of speech and could discourage patients from taking needed medicines.

— What pharma companies and ad makers allege: Merck, Eli Lilly, Amgen and the Association of National Advertisers argue that the rule, slated to take effect in July, would mislead and ultimately discourage patients from trying to get drugs, because they will think the list price is the same that they will pay.

Consumers usually pay lower prices negotiated through insurance coverage, rebates and other factors, they argue.

— How HHS responded: “If the drug companies are embarrassed by their prices or afraid that the prices will scare patients away, they should lower them,” HHS spokesperson Caitlin Oakley said. “President Trump and Secretary Azar are committed to providing patients the information they need to make their own informed health care decisions.”

Read complete article here: 

HHS sued by pharma over rule on prices in ads – POLITICO.

Post a Comment

WP-SpamFree by Pole Position Marketing